Compare SUJA & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUJA | FOCL |
|---|---|---|
| Founded | 2012 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.3M | 222.4M |
| IPO Year | 2026 | 1998 |
| Metric | SUJA | FOCL |
|---|---|---|
| Price | $10.14 | $4.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $18.00 | $8.80 |
| AVG Volume (30 Days) | ★ 273.6K | 85.7K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $70,527,000.00 |
| Revenue This Year | $11.11 | N/A |
| Revenue Next Year | $13.13 | $34.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $5.59 | $4.00 |
| 52 Week High | $11.93 | $6.40 |
| Indicator | SUJA | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 60.92 | 43.20 |
| Support Level | $8.83 | $4.01 |
| Resistance Level | $10.94 | $4.63 |
| Average True Range (ATR) | 0.63 | 0.27 |
| MACD | 0.12 | 0.02 |
| Stochastic Oscillator | 97.05 | 32.59 |
Suja Life Inc operates a beverage platform focused on producing and selling products such as cold-pressed juices, wellness shots, and functional sodas. Its portfolio includes brands such as Suja Organic, Vive Organic, and Slice. The Company operates and manages its business in two operating segments, which are also reportable segments: i) Suja Core: It produces and distributes cold-pressed fresh juice and cold-pressed juice shots. ii) Emerging Brands: It consists of recently acquired or launched brands and products that are still in the early stages of revenue scale, market development, or distribution build-out. The majority of revenue is derived from Suja Core.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.